Outpatient Randomized Controlled Trials in the Covid-19 Era and Beyond.
NEJM Evid
; 1(12): EVIDctcs2200149, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-38319835
ABSTRACT
Outpatient Trials in the Covid-19 Era and BeyondA group of investigators had a meeting at the National Heart, Lung, and Blood Institute in May 2020 to discuss ways to decrease thrombotic complications among symptomatic outpatients with Covid-19. The investigators discuss their approach to three specific challenges conducting a trial remotely, working through regulatory hurdles, and recruiting a diverse population of participants.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
COVID-19
Tipo de estudo:
Clinical_trials
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article